Lau Fellows

The Stockholm node of MWLC currently consists of six scientific teams headed by the first Lau grant recipients, "Lau Fellows", selected in 2016.

The Lau grants were established to support world-leading research in reparative medicine performed at KI and to deepen existing and establishing new research partnerships with top universities in Hong Kong and China. The grants are designed to support group leaders employed by KI at the stage where they are consolidating their own independent research. After rounds of selection, the following six researchers have been identified with cutting-edge expertise consistent with the mission and vision of MWLC. The Lau Fellows are MWLC investigators who form an integrated part of the Centre.

Gonçalo Castelo-Branco, Department of Medical Biochemistry and Biophysics
Modulating the epigenetic state of oligodendrocyte lineage cells to induce remyelination in multiple sclerosis

Simon Elsässer, Department of Medical Biochemistry and Biophysics
Function of short peptides encoded by sORFs (sPEPs)

Christian Göritz, Department of Cell and Molecular Biology
Central Nervous System Scarring and Repair

Francois Lallemend, Department of Neuroscience
Genetic control of neuronal survival: implications for new cancer therapies

Ning Xu Landén, Department of Medicine Solna
Regulatory RNAs in wound-edge keratinocytes: new perspectives towards treating chronic wounds

Fredrik Lanner, Department of Clinical Science, Intervention and Technology
Pluripotency, embryonic stem cells and regenerative medicine

Facts on Lau grants

  • Lau grants are designed to support group leaders at KI at the stage where they are consolidating their own independent research.
  • Eligible to apply were group leaders employed by KI with up to 15 years of experience since completion of PhD (or equivalent degree) and scientific track record showing great promise and with several important publications without the participation of their PhD supervisor.
  • Researchers active within all fields relevant to regenerative medicine could apply, including developmental biology, stem cell research, biomedical engineering, and relevant technologies.
  • Evaluation was done by peer review by international experts outside of KI, on the basis of scientific excellence of the researcher’s track record and research proposal as well as the enhancement of collaboration with Hong Kong and Chinese scientific communities.
  • Research under this grant must be conducted at KI.
  • Decision was announced on 22 September 2016.
  • Each Lau Fellow was awarded SEK 1.6 million per year, for three years.
Content reviewer:
Molly Yang